Correlation of the Serum Insulin and the Serum Uric Acid Levels with the Glycated Haemoglobin Levels in the Patients of Type 2 Diabetes Mellitus

• الحاوية / القاعدة: Journal of Clinical and Diagnostic Research
• المؤلفون الرئيسيون: ANJU GILL, SAHIBA KUKREJA, NARESH MALHOTRA, NAMRATA CHHABRA
• التنسيق: مقال
• اللغة: الإنجليزية
• منشور في: JCDR Research and Publications Private Limited 2013-07-01
• الموضوعات: glycated haemoglobin (hba1c); fasting blood sugar (fbs); serum insulin
• الوصول للمادة أونلاين: https://jcdr.net/articles/PDF/3121/7%20-%206017_E(C)_PF1(PU)_F(H)_PF1(PUH)_PFA(NC)_OLF_H.pdf
• تدمد: 2249-782X; 0973-709X

Background: Type 2 Diabetes mellitus (DM) is a heterogeneous disease which is characterized by variable degrees of insulin resistance and impaired insulin secretion. Insulin is a hormone that regulates the body’s use of glucose. The present study was undertaken to find the correlation of the serum uric acid levels in the patients of Type 2 Diabetes mellitus. Material and Method: This was a case control study. The subjects who were included in the study were divided into two groups. Group A included 50 normal healthy individuals who were in the age group of 40-65 years, who were of either sex and with no family history of Diabetes mellitus. Group B included 50 newly diagnosed patients of Type 2 Diabetes Mellitus, who were in the age group of 40-65 years, who were of either sex, from the same population. Fasting blood samples were drawn and they were investigated for the serum insulin, serum uric acid, fasting blood sugar and the HbA1C levels. The values were compared with those of normal healthy subjects. Results: All the three parameters, HbA1C, serum insulin and serum uric acid were found to be increased in the patients of Type 2 Diabetes Mellitus as compared to their levels in the controls (p<0.001). Conclusion: In the present study, it was concluded that the serum uric acid levels linearly increased with increasing serum insulin levels, in newly diagnosed diabetic patients. Therefore, uric acid serves as a potential biomarker of the glucose metabolism.